In Iowa, Kemin Industries announced a strategic acquisition of unique beta-glucan manufacturing technology from Algal Scientific to expand Kemin’s gut health portfolio. Kemin, a global nutritional ingredient company, welcomes the technology inventors and nearly a dozen new employees with expertise in both production and research to the Kemin team. Kemin will continue product research on these products to further expand application of the technology.
“The acquisition of this beta-glucan manufacturing technology, developed by Algal Scientific, will provide Kemin with capabilities and products needed to further expand our antibiotic alternative portfolio for animals, and offer important scientific advancements for humans and pets,” said Dr. Chris Nelson, President and CEO of Kemin Industries.
“As a start-up, Algal Scientific invented this technology and extensively researched the science behind the differentiated beta-glucan,” said John Tucker, CEO of Algal Scientific. “Kemin is uniquely suited to exploit this technology and offer advanced products to customers globally.”